Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence.

When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes,  driving cancer cells to grow and allowing them to resist treatment.  At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive.

Our Culture:

At Boundless, you’ll experience what it means to be out in front of the wave. 
Our unprecedented science takes us to new shores, and our team navigates the best breaks. We’re leaders in our field, and we’re dedicated to the cause of understanding and treating intractable cancers.

Every employee at Boundless makes an unbridled impact on our capabilities and our culture. We’ll help you expand your abilities and defy your bounds by providing meaningful work and unbounded opportunities. Career development is essential at Boundless. 

We’re all in on this fight against cancer– collaboration is requisite to our success. We have a team of people who ask, offer, and accept help without regard for ego. We know that receiving support is energizing, and giving help is fulfilling. We are inspired by the patients who are reliant upon our success. 

At Boundless, we’re all in. We are unbound by convention, bound to save lives. 


Career Inquiries
careers@boundlessbio.com

General Information Inquiries
info@boundlessbio.com

Wellington Management

GT Healthcare Capital Partners

Alexandria Venture Investments

Surveyor Capital

Vertex Ventures

Boxer Capital

Fidelity Management and Research Company

Nextech Invest

PFM Health Sciences

RA Capital Management

Redmile Group

Fidelity

Logos Capital

City Hill Ventures

ARCH Venture Partners

Piper Heartland Healthcare Capital

Boundless Bio

Today’s bell ringing ceremony was extra special for Boundless Bio, celebrating alongside inspiring students from DREAM New York Charter High School. Thank you Life Science Cares San Diego and Life Science Cares New York for bringing us together. These stellar students helped us ring in our big day all while learning first-hand about the #IPO process and stock market. Thank you for joining us!

A $BOLD step forward for Boundless and patients with oncogene amplified cancer. Today, we celebrate our #IPO at Nasdaq during the opening bell ringing ceremony. 
 
We are energized and committed to our pursuit of novel, potentially life-improving treatment options for patients with oncogene amplified cancers. Thank you to our team, partners, investors and supporters – here’s to our next chapter!

Working with such amazing teammates every day is a wonderful honor. On #InternationalWomensDay and every day, we’re deeply grateful for the commitment and expertise the incredible women of Boundless Bio bring to the table.

Today we’re featuring Claire Kuelbs, one of our Sr. Research Associate’s story in her “Boundless Bio.” Claire fell in love with biology in high school and hasn’t looked back since. By taking advantage of opportunities throughout her career, she’s been able to combine her love of biology and working with people as a mentor. Her advice to other women? “Love what you do and just go do it. There are so many opportunities out there now, so just believe in yourself and go get it.”

Claire represents many successful and courageous women at Boundless and worldwide who shape our lives with their charisma and contributions. Thank you for sharing! 

We’re eager to share that we will be at #AACR24 with multiple poster presentations April 5-10 in San Diego, CA. Our team is looking forward to engaging with other industry leaders and discussing our oral CHK1 inhibitor, BBI-355, as well as #ecDNA-driven cancer. We will be presenting Sunday, Monday and Tuesday. See below for more details. https://lnkd.in/e7GmMG-x

To our BoundTowners: Thank you! 
 
Our #EmployeeAppreciationDay breakfast has been an annual tradition to show deep gratitude for our team. Leaders took to the griddle to flip pancakes for everyone, creating a delightful morning of laughter and connection. Here's to another year of teamwork and success.

Hummingbird Bioscience is a biotechnology company focused on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer and other diseases.

Hummingbird Bioscience

Advanced Accelerator Applications is a radiopharmaceutical company that develops, produces, and commercializes molecular nuclear medicine diagnostics and therapeutics.

Advanced Accelerator Applications

PACT Pharma is a biotechnology company focused on developing personalized adoptive T cell therapies for the treatment of cancer.

PACT Pharma

Lyell Immunopharma is a biotechnology company that develops technologies for the ex vivo expansion and genetic engineering of T cells for cancer immunotherapy.

Lyell Immunopharma

Nanobiotix is a nanomedicine company developing novel approaches for the local treatment of cancer.

Nanobiotix

Elpiscience is a biotechnology company focused on the development of innovative therapies for cancer and other diseases.

Elpiscience

NexImmune is a biotechnology company focused on the development of novel immunotherapies for the treatment of cancer and autoimmune diseases.

NexImmune

Kite Pharma is a biotechnology company that develops and commercializes chimeric antigen receptor T cell (CAR-T) therapies for the treatment of cancer.

Kite Pharma

Intensity Therapeutics is a biotechnology company focused on the development of proprietary cancer immunotherapies for the treatment of solid tumor cancers.

Intensity Therapeutics

Senti Bio is a biotechnology company that engineers gene circuits for cell and gene therapies to treat a wide range of diseases, including cancer.

Senti Bio

Adimab is a biotechnology company that provides a platform for the discovery and optimization of fully human antibodies.

Adimab

DiaCarta is a molecular diagnostics company that develops and commercializes innovative technologies for the detection of cancer and other diseases.

DiaCarta

Mission Bio is a life sciences company that develops and commercializes single-cell DNA analysis tools for the study of cancer and other diseases.

Mission Bio

Quadrants Scientific is a biotechnology company focused on the development of novel therapeutics for the treatment of cancer and other diseases.

Quadrants Scientific

Boundless Bio is a biotechnology company developing ecDNA-directed therapies (ecDTx) to improve and extend the lives of patients with oncogene amplified cancers.

news impact assignment basic	general	May 2, 2024 9:39 PM	8deb34be
public peers	general	May 2, 2024 9:39 PM	9fba7ab6
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 2, 2024 9:39 PM	cd9368b8
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 2, 2024 9:39 PM	a13b9ce5
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 2, 2024 9:39 PM	78db737f
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:BOUNDLESSBIO

Boundless Bio